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right anterolateral mini thoracotomy became safe
technique. In our study we compared mini-MV surgery
with conventional technique regarding cross clamp time,
bypass time, total blood loss, reopening for bleeding, and
hospital and ICU length of stay. In our institution
between 2010 and 2015, 147 patients underwent mini-
mally invasive mitral surgery through right lateral mini-
thoracotomy 8 cm incision and 118 patient underwent
conventional mitral valve surgery through median ster-
notomy in minimally invasive technique: mean age was
38 ± 20 vs 59 ± 21, 70.7% were female (n = 104) vs 39.8%
(n = 47), 23.8% were associated with tricuspid valve
regurgitation (n = 33) vs 55% in conventional technique
(n = 65), 0.08% were able to use endovascular clamp
(n = 12), mean Euroscore predected risk of mortality
14.7 ± 13.6% vs 8.7 ± 10.9%. Minimally invasive mitral
valve repair surgery was accomplished in 77.5%
(n = 114) vs 46.15% (n = 55 ) and replacement of mitral
valve in 22.4% (n = 30) vs 53.8% (n = 64 ), concomitant
procedures consists of tricuspid valve surgery in 23.8%
(n = 35) vs 55% (n = 65), primary mitral valve repair
included implantation of rigid annuloplasty ring in
79.6% vs 38.9% (n = 46), duration of cardiopulmonary
bypass in minimally invasive surgery was 123 ± 64 min
vs 116 ± 62 min, cross clamp time was 64 ± 27 min vs
59 ± 23 min, postoperative mechanical ventilation time
4 ± 1.5 h vs 6.5 ± 2 h, ICU lenght of stay (LOS) was
48 ± 12 h vs 3 ± 1 days. Minimally invasive mitral surgery
can be performed very safely with excellent early results.
mini-MV surgery can be performed with a reasonable
operative time, good perioperative course with decrease
in postoperative ICU and hospital LOS.
http://dx.doi:10.1016/j.jsha.2016.04.004
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Suture-less bio-prostheses (SBP) are a recent addition
in the surgical armamentarium in the surgical treatment
of sever aortic valve disease that offer rapid deployment,
shorter bypass & ischemic times and excellent hemody-
namic performance even in small aortic annulus. We pre-
sent our initial experience and short-term clinical and
hemodynamic results with the use of suture-less
bio-prostheses. Between May 2011 and August 2015, 61
patients, with mean age of 72.6 years and severe aortic
stenosis underwent aortic valve replacement with a
SBP. 28 were males and 19 were females. Mean euro-
SCORE was 11.5. 55% had coronary artery disease, 8.5%
had severe mitral regurgitation and 6.4% had severe tri-
cuspid regurgitation. Left ventricular dysfunction was
present in 28% patients and 83% had elevated right ven-
tricular systolic pressure. Average size of aortic annulus
was 21.7 mm. 42.5% patients underwent isolated aortic
valve replacement while 57.5% had concomitant proce-
dures including coronary artery bypass grafting (25
patients). Average cross clamp time in isolated aortic
valve replacement was 34 min and total bypass time
was 46 min. Mean gradient across the prostheses was
an average of 8.9 mmHg intra-operatively with 4.3% pre-
valence of mild para-prosthetic leak and 10.6% preva-
lence of mild prosthetic regurgitation. In-hospital
mortality was 2.1% (1 patient). At follow-up, average
mean trans-aortic gradients were 15 mmHg and preva-
lence of mild prosthetic and para-prosthetic leak was
10.5%. Average left ventricular diastolic dimensions
changed from 4.93 mm pre-operatively to 4.42 mm post-
operatively (p = 0.023) and left ventricular systolic
dimensions changed from 3.39 mm pre-operatively to
3.05 mm post-operatively (p = 0.124). Use of suture-less
bio-prosthesis for aortic valve replacement produces
excellent hemodynamic results with low incidence of
para-prosthetic leakage and prosthetic regurgitation.
Persistent low trans-aortic gradients and regression of
left ventricular diastolic dimensions seen on follow up
is likely to offer long-term survival benefit.
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Mitral valve replacement (MVR) with either a biopros-
thetic or a mechanical valve is the treatment of choice for
severe mitral stenosis. This study aimed to evaluate and
compare the early and late outcome of mitral valve repla-
cement (mechanical versus bioprosthetic) for severe
mitral stenosis. A retrospective cohort study was per-
formed on prospectively collected data involving mitral
stenosis patients who have undergone MVR with either
bioprosthetic (BMV) (n = 50) or mechanical (MMV)
(n = 145) valves in our institute from 1999 to 2012. Data
were analyzed for early and late mortality, NYHA func-
tional classes, stroke, early and late valve-related compli-
cations, and survival. Chi Square test, logistic regression,
Kaplan Meier curve, and dependent proportions tests
were performed. A total of 195 patients were included
in the study with a follow-up of 190 patients (97.5%).
One patient died early post-operatively; twelve patients
died late in the post-operative period, BMV group (6)
and the MMV (6). The Late mortality had significantly
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